Class II
Ongoing
CLEVIPREX (clevidipine injectable emulsion) 50 mg/100 mL (0.5 mg/mL), 10 Single Use Vials, Rx Only, Manufactured for: Chiesi USA, Inc., Cary, NC 27518, by Fresenius Kabi, Graz, Austria, NDC 10122-611-…
Why: Lack of Assurance of Sterility
- Company
- Chiesi USA, Inc.
Cary, NC, United States - Reported
- Jul 22, 2026
- Recall started
- Jul 6, 2026
- Where sold
- Nationwide within the United States
- Amount
- 44280 vials
- Full product description
- CLEVIPREX (clevidipine injectable emulsion) 50 mg/100 mL (0.5 mg/mL), 10 Single Use Vials, Rx Only, Manufactured for: Chiesi USA, Inc., Cary, NC 27518, by Fresenius Kabi, Graz, Austria, NDC 10122-611-10.
- Lots / codes affected
- Lot #: 1239521, 1237454, Exp. Date 10/2027
Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.